Fluarix Tetra

Fluarix Tetra is a quadrivalent influenza vaccine designed to protect against four strains of the flu virus. This vaccine is administered intramuscularly and is manufactured by Glaxosmithkline B.V. in the EU.

Fluarix Tetra is used to prevent influenza caused by the B/Phuket/3073/2013-like virus and the Influenza Virus B/Austria/1359417/2020. It is typically recommended for individuals seeking protection against seasonal flu strains. This vaccine is part of a broader category of flu shots aimed at reducing the risk of influenza infection.

Common effects of Fluarix Tetra may include soreness at the injection site, mild fever, and fatigue. These effects are generally mild and temporary, resolving within a few days. As with any vaccine, individual responses can vary.

Fluarix Tetra should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to previous influenza vaccines or any components of this vaccine should consult their healthcare provider before use. Always inform your healthcare provider about any medical conditions or allergies.

Fluarix Tetra may interact with certain medications or health conditions. It is important to discuss any current medications or health issues with a healthcare provider before receiving this vaccine. Specific interactions with alcohol or other substances are not typically noted, but general health precautions should be followed.